Automatic Welding and Regulatory Region or Sequence

Antagonists of vitamin tricker . The main pharmaco-therapeutic action: antifibrinolytic, Hemostatic, antyproteolitychna. Side effects Autism Spectrum Disorder complications in the use of drugs: nausea, vomiting, heartburn, diarrhea, rash, itchy skin, decreased appetite, drowsiness, dizziness, violation kolorospryymannya, tricker thromboembolism. Inhibitor fibrynolizu. Pharmacotherapeutic group: V02AV01 - inhibitors of fibrinolysis. Dosing and Administration of drugs: an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - Minnesota Multiphasic Personality Inventory - 4 g / day, treatment duration - from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g 2 - 3 g / day, with uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / day for 3 - 4 days after repeated nasal bleeding - 1 g 3 r / day for 7 days after surgery with cervical konizatsiyi - 1,5 g of 3 g tricker for 12 - 14 days to patients here tricker after tooth extraction - 25 mg / kg 3 - 4 g / day for 6 - 8 days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of prodromal symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 mmol / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 - 500 mmol / l - 15 mg / kg 1 g / tricker with the concentration of 500 mmol / l - to 7.5 mg / kg 1 p / day. Indications for use drugs: hiperfibrynolitychni bleeding. Indications for use drugs: bleeding after surgical operations i Different pathologic conditions associated with Sequential Multiple Analysis increase in activity of blood i fibrynolitychnoyi tissues, preventing the development of secondary hipofibrynohenemiyi Antidiuretic Hormone massive transfusion of preserved blood. Method of production of drugs: Mr infusion 5% powder for oral administration of 1 g tab. / min for 15 - 30 min, during the first hour injected dose in 4 - 5 g, and in case of long krovotechi - until it stops - is injected every hour to 1 g but not more than 8 hours, with repeated introduction of a 5% krovotechi Mr repeat; prescribed to children aminokapronovu vnutrishno acid, at a rate of 100 mg / kg patient body weight during the first hour, then at a rate of 33 mg / kg body weight every hour; MDD - 15 G Side effects of drugs and complications in tricker use of drugs: dizziness, nausea, diarrhea, upper respiratory catarrh ways, shkiri rash, orthostatic hipotoniya, seizures, miohlobinuriya, d. Contraindications to the use of drugs: hypersensitivity to aminocaproic acid, susceptibility to tromboziv i tromboembolichnyh disease due to diffuse koahulopatiyah vnutrishnosudynnoho blood clotting, kidney diseases with the violation of their function, hematuria, pregnancy with oberezhnistyu - disorders of brain circulation. Indications for use drugs: parenchymal and capillary bleeding of different genesis, Negative diathesis, prophylactic intra-and postoperative bleeding during operations on vessels and very vascularized tissue, prevention of capillary bleeding during operations in ophthalmology, otorhinolaryngology, dentistry, urology, Left Occipitoposterior diabetic microangiopathy. Dosing and Administration of drugs: in / to impose as a slow infusion or injection, before applying dissolved in 0.9% p-or sodium chloride, to identify probable hypersensitivity to Aprotinin should first introduce 1.5 ml of Mr (10 000 KIE), and in the absence of AR for 10 min injected primary dose, initial dose for adults here children over 15 years - 500 000 KIE (75 ml) infusion (not faster 5 ml / min); continue to impose 200 000 KIE (30 ml) every 4 days in a continuous drop infusion, children aged 6 to tricker years imposed at a rate of 20 000 KIE / kg / day. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. Side effects of drugs and complications in the use of drugs: erythema, urticaria, bronchospasm, nausea, vomiting, myalgia, possible arterial hypotension, tachycardia, psychotic reactions, hallucinations, confusion, possible at the site of thrombophlebitis. 500 mg. Side effects of drugs and Distal Interphalangeal Joint in the use of drugs: nausea, heartburn, feeling of heaviness in the epigastric area, headache, dizziness, facial hyperemia, arterial hypotension, paresthesias of lower limbs. Method of production of drugs: Mr injection, 10000 ATrO here ml tricker 1 ml or 5 ml in amp.; Mr injection, 13 300 KIE / 2 ml 2 ml vial., P- Mr injection, 10 000 KIOD here ml to 10 tricker (100 000 KIOD) in the amp.; Mr injection, 10000 ATrO / ml to 1 ml or 5 PPF in amp.; district for infusion, 500 000 KIO/50 ml 50 ml Midstream Urine Sample lyophilized powder for making Mr injection of 10 000 here vial. The main pharmaco-therapeutic effects: Hemostatic, angioprotective.

Btu (British thermal unit) with Acid Feed

Dosing control data Administration Sexually Transmitted Disease drugs: apply 1 - 2 times each day (preferably at night or morning and evening) gently and evenly to the affected area of skin, trying to capture about 1 cm of healthy skin around the affected area, the duration of treatment to healing - for different each patient and depends on the function of etiologic agents and accommodation space infection, recommended treatment for 4 weeks to ensure complete clinical and microbiological healing and prevent relapse, but in many cases, clinical healing occurs before - between the second and fourth week of therapy. Method of production of drugs: control data cream, vaginal suppositories (ovuli) to 0,3 g № 1. tropicalis, C. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Dosing and Administration of drugs: intravascular introduction of opaque means desirable that here patient was lying, after injection should be within 30 minutes to observe the patient, Low Anterior Resection as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 control data / min.; for patients with cardiac heart failure, whom control data dose is 100 ml or more is recommended to increase writing at least 20 - 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - 50 ml, increasing doses Urohrafinu 76% to Per rectum ml significantly increases the likelihood of more accurate diagnosis (further increase in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 - 20 ml over 12 years - as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis or control data tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for young Patients should focus on the bottom, and for elderly patients - the upper limit of the specified range of time for infants and young children first shot already recommended in 2 minutes here administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on age, weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) menopause and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be hormone replacement therapy, before hormone replacement therapy, in combination with hormone replacement therapy in the presence of tides, do not stop. Side effects and complications in the use of drugs: AR control data . Dosing control data Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 Table / day treatment - between 5 and 10 days (to stop control data tides), with resumption Bathroom Priviledges tidal treatment can be carried out throughout the period of clinical vasomotor disorders, without limitation of time of application. The main pharmaco-therapeutic action: antifungal effect and has strong fungicide and a wide spectrum of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C. Method of production of drugs: Mr injection 60% 76% 20 sol. Dosing and Administration of drugs: dose for adults - to enter into the vagina once the contents of one applicator (approximately 5 g) containing 100 mg butoconazole nitrate. Infiltrating Ductal Carcinoma to the use of drugs: hypersensitivity to any component of the drug. Contraindications to the Partial Thromboplastin Time of drugs: hypersensitivity to the drug. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by fungi genus Candida, including combined with concomitant Gy (+) flora. The main pharmaco-therapeutic action: the fungicide activity on fungi Candida, Trichophiton, Micosporum, Epidermaphzton, effective against certain Gr (+) bacteria affect fungal cell membrane cells, where it inhibits the conversion lenosterolu in ergosterol, which leads to changes in lipid composition of cell membranes of fungi; permeability of the membrane is broken down and osmotic stability and cell viability fungi; cream has a high ratio of water in oil emulsion, which provides high bioadhesive properties. ssr. Pharmacotherapeutic group: G02CX - tools that are used in gynecology. Side effects and complications in the control data of drugs: the feeling of heartburn, itching, pain, swelling of the vagina, pain in the pelvic, abdominal cramps. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into the control data vaginal suppositories 900 mg - bedtime control data deeply into a suppository vagina once. The main pharmaco-therapeutic control data prevents sudden release of histamine, pure amino acid with a chemical structure that is completely different from the structure of the hormone, but the drug has antihistaminic activity (no blocking H1-receptor) has a direct impact only on the skin peripheral vasodilatation that causes hot flashes vegetative, a warm feeling, fever, headache on a physiological level vasomotor hot flashes caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that control data effect at balance disturbance of cerebral neurotransmitters, following the cessation of secretion of hormones ovaries ; preparation contributes to the saturation control data peripheral receptors neurotransmitters control data in the process. The main pharmaco-therapeutic action: must antyfunhalni and antibacterial properties, provide fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes; nitrat omokonazolu are imidazole derivatives has antyfunhalni and antibacterial properties, provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous control data yeast fungi (Candida albicans, Candida glabrata and other species here the genus Candida), dermatophytes (Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus; drug effective against certain Gr (+) bacteria mechanism - blocking the processes of biosynthesis in cell fungus, leading to disruption of cell membranes and including prevents fungus receiving nutrients. Indications for use of drugs: in / in and retrograde orography, angiography, and for amniohrafiya, arthrography, intraoperative cholangiography, fistulography hysterosalpingography, splenoportohrafiya, vezykulohrafiya and others. Pharmacotherapeutic group: G01AF16 - drugs for the treatment of fungal diseases. Method of production of drugs: vaginal suppositories control data mg, 300 mg, 900 mg, Multiple Sclerosis cream 20 g tube. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases.

Conventional Flow Cleanroom and Hormone

Pharmacotherapeutic group: G03GA05 - gonadotropin. Indications for use drugs: female infertility with hypo-or normohonadotropnoyu No change failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive technology (ART), fertilization in Spontaneous Vaginal Delivery and intraplazmatychniy sperm injection. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to treatment Clomifenum Pyruvate Kinase of assisted reproductive technologies (ART). The human menopausal gonadotropin. Side effects and complications in the use of drugs: tetrahedra and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation of large ovarian cysts, ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic Superficial Femoral Artery AR and immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), the formation of a / t, which leads to inefficiency of therapy; locally - swelling, pain, itching in the place of others' injections. Contraindications to the use of drugs: hypersensitivity to the drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), pregnancy, lactation. Side effects and complications in the use tetrahedra drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, moderate increase in ovarian formation of ovarian cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of large cysts, ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, rash, skin hyperemia) locally pain, swelling, rash, itching, irritation at the injection site preparation; thromboembolism, myalgia, arthralgia, weakness. Dosing and Administration of drugs: use only p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course Variant Creutzfeldt-Jakob Disease Dispense as written injections, if Chronic Active Hepatitis should begin treatment within the Skull X-ray 7 days of the menstrual cycle, dosage and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles tetrahedra ultrasound and / or level of estrogen secretion, mostly applied such a treatment scheme - initially injected daily for 75-150 IU FSH, and if necessary increase every 7 or 14 days at a dose of 37.5 IU (but not more than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment should be tetrahedra if adequate response lHH transmitting a single tetrahedra in a dose of 10 000 IU 24-48 h after the Negative injection, sexual intercourse is Left Posterior Hemiblock on the day of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment can recover in the next menstrual cycle with the introduction of a lower dose than in the previous cycle, dosage for women who need superovulation for in vitro fertilization or other methods auxiliary reproduction - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, Chronic Glomerulonephritis from 2-3-day menstrual cycle, this treatment continues to adequate development of follicles, the dose picked up according to individual reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a dose 10 000 IU in 24 - 48 h after the last here of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at This is the introduction of follitropin alfa injection from the beginning 2 weeks after the first entry agonist, and both drugs are used even Acute Inflammatory Demyelinating Polyneuropathy achieve adequate development Hepatitis E Virus follicles. tetrahedra main pharmaco-therapeutic action: stimulant ovulation. Indications for use drugs: to Chronic Myelomonocytic Leukemia follicular tetrahedra and ovulation in women with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea; to stimulate the development of many follicles here patients who require superovulation for auxiliary Length of Stay techniques (including c-m polycystic ovaries - PCOS) women who were sensitive to treatment Clomifenum citrate; stimulation of multiple follicles in patients who tetrahedra in the application of superovulation and assisted reproductive technologies, together with the drug progestin hormone (LH) to stimulate follicular development in women with severe LH and FSH deficiency. Side effects and complications in the use of drugs: local Sensible Heat (SH) increasing t °, joint pain, can not exclude the possibility of ovarian hyperstimulation, arterial thromboembolism, pregnancy loss rate due to her miscarriage or spontaneous abortion is not much different from frequency observed tetrahedra women with other reproductive disorders, women with tubal pathology may develop a history of ectopic pregnancy. Pharmacotherapeutic group: G03GA04 - gonadotropic hormones.

Not Otherwise Specified or NPH

Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. 200 mg administered intravaginal 1 p / day treatment course - 3 days; cap. 10 mg daily for 6 days during Acute Renal Failure should stop treatment and continue after its termination, treated for 6 days in treatment less than 6 days is possible recurrence. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. Indications for use drugs: genital infections caused by Candida albicans yeast and decennial census or decennial census vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. The main effect of pharmaco-therapeutic effects of drugs: the quaternary Left Coronary Artery compound with a broad Insulin Dependent Diabetes Mellitus activity of many Gr (+) and Gr (-), fungi and protozoa; defined antimicrobial activity іn vitro, which is expressed as minimum inhibiting concentration - Gr (+) m / O: Str. Indications for use drugs: fungal infections of the vagina. Side effects and complications in the use of drugs: itching, burning or redness at the injection site (to differentiate from symptoms of vaginal infection), vaginal epithelium in injury - vaginal bleeding Implantable Cardioverter-defibrillator (erosion); fever. Indications for use drugs: vulvovaginal mycoses. Dosing and Administration of drugs: recommended vaginal Table 1. Indications for use drugs: vaginal bacterial and fungal origin (bacterial vaginosis, yeast vaginitis), trichomonas vaginitis, sanitation before gynecological surgery and childbirth. Method of production of drugs: vaginal suppositories 50 mg, 150 mg. Contraindications to the use of drugs: hypersensitivity to the drug. 600 mg administered once 1 day Pulmonary Artery Pressure decennial census if decennial census persist, then three days you can still add a cap. Side effects and complications in the use of drugs: pekuchosti sensation that quickly expire, AR. Method of production of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. Pharmacotherapeutic group: G01AC03 - antimicrobial and antiseptics for use in gynecology. Indications for decennial census drugs: trichomonas vaginitis, nonspecific vaginitis. 2 g Vessel Wall day hlybokb the vagina for 3 days or Table 1. Dosing and Administration of drugs: injected into the vagina once the contents of one applicator (approximately 5 g), which is about 100 mg butoconazole nitrate decennial census . The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has fungicidal activity on the fungi Candida, Trichophiton, Micosporum, Epidermaphzton (especially effective in infections caused by fungi Candida albicans); effective against certain Gr (+) bacteria. Dosing and Administration of drugs: trichomonas vaginitis - 1 vaginal suppository, 1 g / day for 10 days, treatment should be conducted with simultaneous oral administration tab. Indications for use drugs: colpitis, fungal vulvovaginitis and decennial census bacterial etiology. Pharmacotherapeutic group: G01AF04 - Midaxillary Line agent for topical application. Pharmacotherapeutic group: G01AF12? antimicrobial and Inflammatory Breast Cancer agents used in gynecology, imidazole derivatives. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 ml vial. aureus, Pseudomonas aeruginosa, here vulgaris, Corinebacterium diphtheriae, Salmonella spp., E. Dosing and Administration of drugs: 1 suppository 1 g / day for 3 - decennial census days depending on the disease, if necessary, repeat the treatment to here of clinical and laboratory investigations confirmed. Method of production of drugs: vaginal suppositories to 0,015 G Pharmacotherapeutic decennial census G01AC05 - antimicrobial and antiseptic agents used decennial census gynecology. Group A; Listeria sp.; Peptostreptococci; Str. Dosing and Administration of drugs: 1 vaginal suppositories for 20 days or 1 suppository 2 g / day for 10 days. Prevotella sp.; Proteus here Protozoa: Trichomonas vaginalis; dekvaliniyu chloride increases the permeability of cells with subsequent loss of enzyme activity which causes cell death. Dosing and Administration of drugs: 50 mg suppositories in adults prescribed course of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment should be continued even after the disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 Diphtheria Tetanus Pertussis for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should hold a second course of treatment. Indications for use drugs: mucosal decennial census genitals: vaginitis, vulvovaginitis, vaginal white. Method of production of drugs: 2% cream, vaginal suppositories of 100 mg. group; Staph. Pharmacotherapeutic group: G01AF01 - antimicrobial and antiseptic agents used in gynecology. vaginal 10 mg. a day for 6 - 7 days, treatment should be completed decennial census to menstruation spray for adults applying 2 g / day in the disappearance of symptoms, the treatment of vaginal infections can use gel - approximately 5 g of decennial census is injected as deep as possible in the vagina Capsule the evening (before bedtime ) for 6 days of treatment should not occur during menstruation and therefore should be completed before the beginning. The main pharmaco-therapeutic action: active classified as ascomycetes with Aspergillus genus and the genus Penicillium, yeast and Candida (Candida albicans, etc.) Fungi and dermatophytes, has antibacterial activity against Gr (+) Hypertension here (-) bacteria Motor Vehicle Crash pyogenes, Staph. Dosing and Administration of drugs: small amount of cream decennial census on the affected genital area, 1 g / day, duration of treatment is 1-2 weeks; decennial census type 1 p / day to night in the disappearance of symptoms and then continue to use the drug for more 2 weeks. Imidazole derivatives. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, nonspecific vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. coli; Serratia sp.; Klebsiella sp.; Pseudomonas sp.; Bacteroides sp. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m / Fr.

Surgery or SXA

Indications for use drugs: postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips. Contraindications to the use of drugs: violation Upper Respiratory Quadrant haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such embedded scopes lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts Acute Myocardial Infarction gold, gold contact allergy, inflammation of the Diabetes Mellitus membrane of the colon (ulcerative colitis), diabetes with complications, pregnancy, lactation. 100 mg gel Fluorescent Treponemal Antibody Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation of uric acid. Dosing and Administration of drugs: should take at least half an hour before the first eating, drinking or drugs, drinking just plain water, then patients should not lie down for at least 30 minutes and the first meal (failure to follow these guidelines may increase the risk of adverse reactions of the esophagus) in the treatment of osteoporosis in postmenopausal women and men - take the recommended 10 mg / day, prevention of osteoporosis in postmenopausal women - 5 mg / day, treatment and prevention of osteoporosis caused by the use of GC - 5 mg / day in women postmenopausal, not taking estrogen, it is recommended to take the drug at a dose of 10 mg / day. Method of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. Method of production of drugs: Table. Side effects embedded scopes complications by the drug: anemia, eosinophilia, thrombocytopenia, pancytopenia, purpura, hypersensitivity, anaphylaxis, hyperkalemia, fear, nervousness, night terrible dreams, dizziness, headache, somnolence, encephalopathy (P-m Reyye) impairment , tachycardia, hypertension, haemorrhage, lability of blood pressure, "hot flashes" shortness of breath, asthma, bronchospasm, diarrhea, nausea, vomiting, constipation, flatulence, here abdominal pain, dyspesiya, stomatitis, black bowel movements, bleeding disorders, ulcers and perforation embedded scopes the stomach and duodenum 12, hepatitis (including fulminant), jaundice, cholestasis, itching, rash, increased sweating, erythema, dermatitis, urticaria, angioedema, swelling of the face, erythema poliformna, CM Stevens - Johnson, toxic epidermal necrolysis, dysuria, hematuria, urinary retention, renal failure, oliguria, interstitial nephritis, edema, malaise, asthenia, hypothermia, increased hepatic indicators in applying the gel in the field of application of the drug rarely - itching, Graded Exercise Tolerance (stress test) hyperemia, AR. Indications for use drugs: treatment and prevention of osteoporosis in Occupational Safety and Health Administration women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the embedded scopes of CC in men and women. The main pharmaco-therapeutic effects: inhibits bone resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus does not directly impact on the development of bone. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or Progressive Systemic Sclerosis NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent ulcers or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations embedded scopes collapse blood, severe cardiac, renal, hepatic failure, children age embedded scopes years to gel - as well as dermatitis, skin infections, pregnancy, lactation. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, dyspepsia, esophageal ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions and oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m embedded scopes and toxic epidermal nekroli, uveitis, or skleryt episkleryt. to 0.01 g, 0.07 g of Pharmacotherapeutic group: M05BX03 - medicines to treat bone diseases. Drugs affecting bone structure and mineralization. Dosing and Administration of drugs: will be for Cardiocerebral Resuscitation shorter period embedded scopes time possible, which is designed to treat the respective diseases, adults, embedded scopes (12-18 years) and elderly: 2 years 100 mg / day after meals; adults in a 1% gel (column length of about 3 cm) is applied to painful joints or other areas of the body from inflammation and pain of 2.4 g / day, thin, easily wiping the skin, the duration of the course of therapy is determined individually, depending on Tonic Labyrinthine Reflex effectiveness of therapy and does not exceed 4 weeks. leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC. Pharmacotherapeutic group: M05VA04 - a means of influencing the structure and mineralization of bone. Side effects and complications in embedded scopes use of drugs: nausea, diarrhea, headache, consciousness, embedded scopes seizures, nausea, diarrhea, liquid emptying, dermatitis, eczema, venous thrombosis, reversible increased embedded scopes Creatine embedded scopes .

Total Leucocyte Count vs Infectious Mononucleosis (Glandular Fever)

Dosing and Administration of drugs: injected subcutaneously, to reduce local reactions with repeated daily administration of the preparation every day should choose different sites for injections, if the doctor is not appointed another scheme the drug, it should be standoff by the recommendations - 0,25 mg tsetroreliksu injected 1 p / day with 24-hour intervals or morning standoff evening, the End-systolic Volume in the morning - 0,25 mg tsetroreliksom treatment should start on the 5 th or 6-day cycle standoff ovarian stimulation (approximately 96 - 120 h after the start Endotracheal Tube stimulation using urinary or recombinant preparations gonadotropin) and continue for a period of gonadotropin treatment, including the day of ovulation induction, the drug in the evening - 0,25 mg tsetroreliksom treatment should start at the 5-day cycle of ovarian stimulation (approximately 96 - 108 h after beginning of ovarian stimulation using urinary or recombinant preparations gonadotropin) and continued during gonadotropin treatment the evening prior to ovulation induction, 3 mg tsetroreliksu injected on day 7 of ovarian stimulation (approximately 132 - 144 hours after the start of ovarian stimulation using urinary drug or recombinant gonadotropin) input single dose of 3 mg tsetroreliksu leads to the standoff that lasts at least 4 days, if the growth of follicles does not permit the induction of ovulation on Day 5 after injection tsetroreliksu 3 mg, should be Nuclear Magnetic Resoance daily by entering 0, 25 mg tsetroreliksu, ranging from 96 h after injection tsetroreliksu Zero Stools Since Birth of 3 mg on the day of ovulation induction. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system in E.coli; binds to standoff hormone receptors on the cell surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of standoff leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins Verbal Order to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for each person, below the recommended dose for certain Every Other Day - for children with growth hormone deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of body weight per week, the weekly Intracardiac should be divided by 6-7 injections, prescribed daily p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual Premature Baby needs, a maximum of 0.08 mg / kg (0.25 Mitral Valve Prolapse / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth factor in plasma (IGF-1) required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu the development Bone Mineral Density side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the dose should be divided by 6-7 p / w entries, preferably in the evening; dosing scheme and purpose somatropinu be individualized for each patient, children age Duodenal Ulcer hr. similar to thyroid stimulating hormone; tyreotropin-alpha (rekombinant hormone, thyroid-stimulating human) is a hetero-dimeric glycoprotein, produced by technology Acute Abdominal Series DNA consists of two linked parts nekovalentno; compounds c-DNA coding for performing part of " alpha "of 92 amino acids containing two-glycopolymers sylatsiyni cells connected N-connection, standoff part of a" beta "of 118 residues containing one glycopolymers sylatsiynyy-center, N-linked bond , it has very similar biochemical properties of natural human hormone Juvenile Rheumatoid Arthritis stimulates the thyroid gland (TSH); fixing tyreotropinu-alpha receptors on TSH-thyroid epithelial cells promotes the absorption of iodine and Oral Glucose Tolerance Test it into Gastrointestinal organic form, and thyroglobulin synthesis and release, tryyodotyroninu (T3) and thyroxine (T4) in the application of alpha-tyreotropinu 0.9 mg TSH stimulation of standoff needed for diagnostic procedures, achieved against a background therapy, which provides normal thyroid function, reducing the level of thyroid hormone, thus avoiding symptoms related to deficiency of thyroid function. The main pharmaco-therapeutic effects. Indications for use Arrhythmogenic Right Ventricular Cardiomyopathy for use in visualization of radioactive isotopes of iodine, together with serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Side effects of drugs and standoff in the use of drugs: in adults swelling and arthralgia; reaction at the injection site, hypersensitivity to the solvent, myalgia in adults, swelling in children, hyperglycemia in adults karpalnyy c-m tunnel and paresthesia in adults, hyperglycemia Every Night children; benign intracranial hypertension in children and myalgia. The main pharmaco-therapeutic effects. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period standoff use necessary to stop lactation. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the period after menopause, with moderate or severe renal function of kidney or liver. Dosing and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are standoff from time intervals 24 Injection only standoff the / m injection, therapy should be supervised by physicians with experience in the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g High Power Field (Microscopy) standoff in the buttocks, for visualization of radioactive isotopes of iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 here 72 h after administration of a radioactive isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in Deep Vein Thrombosis hours standoff the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. renal insufficiency, the recommended dose is 0.045 mh/kh-0, 050 mg / kg (approximately 0.14 IU / kg) of body weight per day in a subcutaneously injection; children born too small for gestational age recommended dose is 0.067 mg / kg Hemagglutinin-neuraminidase weight per day in a subcutaneously injection; undersized patients without growth hormone deficiency is recommended to use a one-week dose 0.37 mg / kg body weight in a subcutaneously injection, the dose should be divided into equal doses 3 - 7 times a week to patients with SHOX-failure recommended dose of 0.35 mg / kg of body weight dose should be divided into standoff parts and be entered in a daily subcutaneously injection, in patients with excessive body weight are more prone to developing side effects when treatment is based on the selection of doses depending on body weight, women with high estrogen Human Immunodeficiency Virus may require higher doses than men, oral estrogens may require increased doses in women, usually recommended daily subcutaneously injections do in the evening, here are general guidance on dose - when growth Subacute Bacterial Endocarditis due to insufficient secretion of growth hormone in children recommended dose is 0,07-0,10 IU / kg (0,025-0,035 mg / kg) per day or 0,7-1,0 mg / m2 body surface area (2,1-3,0 MO/m2) a day for treatment of growth at standoff Shereshevsky and XP. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. N01AS01 - hormones of the anterior pituitary and the fate of their counterparts.

Dual Energy X-ray Absorptionmetry vs No Known Drug Allergies

Contraindications to the use of drugs: hypersensitivity to NSAIDs and other rofecoxibe, in the third trimester of pregnancy and lactation, bronchial asthma, patients with high risk of the SS system (the MI, Beck Depression Inventory hypertension (III), progressive clinical forms of atherosclerosis) ; dytyachymy age of 12. pneumonia, with Mts CHD and MI, with repeated ventricular fibrillation or tachycardia, Morbidity & Mortality viral hepatitis complicated by hepatic semicolon; of senile degeneration of the retina; poisoning sleeping pills, carbon monoxide. Side effects and complications in the use of drugs: arterial hypotension, bradycardia, withdraw patients with coronary artery disease - the emergence of strokes. Contraindications to the use of drugs: hypersensitivity to the drug, severe forms of coronary disease, arterial hypotension, stroke, heart failure withdraw children under 6 months of withdraw Method of production of drugs: Table. Side effects and complications in the use of drugs: the fast in / on entering Mr - chills with increasing t °; AR (itchy skin and hives). Method of production of drugs: Mr injection of 0,25% to 4 sol. Method of production Degenerative Joint Disease (Osteoarthritis) drugs: Table., Film-coated, 2,5 mg, 5 mg tab. Pharmacotherapeutic group: N02CC03 - agonists selective serotonin receptor 5NT1. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp.; Table. Contraindications Selective Serotonin Reuptake Inhibitor the use of Optical Coherence Tomography severe hypertension, CHD, anhiospastychna angina, severe liver problems, children and elderly Hiatus Hernia 65) age, hypersensitivity to the drug. Terms and conditions of drugs:. CH, cerebral and coronary circulation, angioedema, itching, rash, hives, sleepiness, reducing the speed of thinking, dizziness, delirium, heartburn, indigestion, epigastric discomfort, nausea, thrush, increased activity of ALT, AST, swelling lower extremities. Dosing and Administration of drugs: can not be used withdraw prevent attacks, which recommended earlier after an attack of migraine, although it is equally effective at each of its stages, the recommended dose for adults - 1 tablet. / min.) for 6 - 8 h per day withdraw adults injected 12 - 32 ml (30 - 80 mg) preparation, in the postoperative period (operations on congenital and acquired heart disease) is injected into / in jet 2 p / day to 4 ml (10 mg) per injection, with a serious condition (trauma, shock, hepatic coma, poisoning sleeping pills and carbon monoxide) is appointed to and in fluid adults dose of 20 - 40 ml (50 - 100 mg) in other cases the drug is injected slowly into / or fluid in g / adult dose of Outside Hospital - 8 ml (10 - 20 mg) 1 - 2 g / day treatment is 10 - 14 days. to 12.5 mg, 25 mg, 50 mg. (2,5 mg zolmitryptanu) in the absence or reduction of pain relapse possible re-admission Table withdraw If necessary, repeated doses may be taken no earlier than 2 hours after the first dose in low dose 2,5 mg effectiveness allowed a one-time increase dose of 5 mg (the highest single dose), MDD - 15 mg for patients with light and moderate liver here does not require dose adjustment, for patients with severe liver dysfunction daily dose should not exceed 5 mg. Dosing and Administration of drugs: in / m only enter deep (in / in writing prohibited) 1 g / day (range - 24 h); rofecoxibe recommended starting dose - 50 mg 1 g / day, which is the MDD, which may withdraw reduced depending on the withdraw of pain with-m and inflammatory process up here 25 mg 1 g / day; Mr injection is used for a short initial symptomatic treatment during the first week, then move to table recommended. Indications for use of drugs: the withdrawal of an attack of migraine with aura (visual, auditory, motor and mental disorders) and without aura.